Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance and pharmacokinetics study of radiolabeled BAY 1021189 in healthy male volunteers
NL-OMON40889Active, not recruiting
- Sponsor
- Bayer
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vericiguat oral suspension in heart failure (HF), sponsored by Bayer. Primary endpoints: Pharmacokinetics and Metabolic disposition and mass balance. Started Apr 2014; status: active, not recruiting.
02
Drugs
vericiguat oral suspension
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NL-OMON40889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40889.